The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: A systematic review and economic evaluation

G Mowatt, G Scotland, C Boachie, M Cruickshank, J A Ford, C Fraser, L Kurban, T B Lam, A R Padhani, J Royle, T W Scheenen, E Tassie

Research output: Contribution to journalArticlepeer-review

99 Citations (Scopus)


In the UK, prostate cancer (PC) is the most common cancer in men. A diagnosis can be confirmed only following a prostate biopsy. Many men find themselves with an elevated prostate-specific antigen (PSA) level and a negative biopsy. The best way to manage these men remains uncertain.
Original languageEnglish
Pages (from-to)vii-xix, 1-281
JournalHealth Technology Assessment
Issue number20
Publication statusPublished - May 2013


  • Biopsy
  • Cost-Benefit Analysis
  • Diffusion Magnetic Resonance Imaging
  • Humans
  • Magnetic Resonance Imaging
  • Magnetic Resonance Spectroscopy
  • Male
  • Prostate
  • Prostatic Neoplasms

Cite this